Bempedoic Acid: A Novel ATP Citrate Lyase Inhibitor for Cholesterol Management
The innovative solution for managing high cholesterol when statins are not an option.
Get a Quote & SampleProduct Core Value
Bempedoic Acid
Bempedoic Acid is a pioneering pharmaceutical compound designed to address hypercholesterolemia, offering a critical treatment pathway for individuals who cannot tolerate statins or require additional LDL cholesterol reduction. Its unique mechanism targets ATP citrate lyase, a crucial enzyme in the liver's cholesterol synthesis pathway.
- Explore the bempedoic acid mechanism of action to understand its targeted approach to cholesterol reduction.
- Learn about bempedoic acid side effects to make informed treatment decisions.
- Discover how to buy bempedoic acid for effective hypercholesterolemia management.
- Understand the significant impact of bempedoic acid for statin intolerant patients in improving cardiovascular health.
Key Advantages
Novel Mechanism
Bempedoic acid inhibits ATP citrate lyase (ACLY), a key enzyme in cholesterol synthesis, providing a novel approach distinct from statins.
Statin Intolerance Solution
This compound offers a vital therapeutic option for patients who experience adverse effects from statins, ensuring effective cholesterol lowering is still achievable.
Clinical Efficacy
Bempedoic acid clinical trials have demonstrated its safety and efficacy in reducing LDL cholesterol levels, supporting its role in cardiovascular health.
Key Applications
Hypercholesterolemia Treatment
Primarily used to manage high cholesterol levels in adults, particularly those with heterozygous familial hypercholesterolemia or established atherosclerotic cardiovascular disease.
Cardiovascular Disease Management
By effectively lowering LDL cholesterol, it contributes to the broader management and prevention of cardiovascular events.
Statin-Alternative Therapy
Provides a crucial alternative for patients who are statin-intolerant or for whom statins are contraindicated, ensuring treatment continuity.
Adjunct Therapy
Can be used in combination with statins or other lipid-lowering therapies for patients needing further LDL-C reduction.